ALKS

Alkermes (ALKS)

Alkermes PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALKS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/25	21:00	PR Newswire (US)	Alkermes to Host Investor Event to Review Orexin Portfolio Strategy	NASDAQ:ALKS	Alkermes PLC
2024/09/23	20:00	PR Newswire (US)	Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024	NASDAQ:ALKS	Alkermes PLC
2024/09/20	05:00	PR Newswire (US)	Alkermes to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Conference	NASDAQ:ALKS	Alkermes PLC
2024/09/13	20:00	PR Newswire (US)	Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program	NASDAQ:ALKS	Alkermes PLC
2024/09/13	20:00	PR Newswire (US)	Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards® Program	NASDAQ:ALKS	Alkermes PLC
2024/08/29	05:00	PR Newswire (US)	Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	NASDAQ:ALKS	Alkermes PLC
2024/08/29	05:00	PR Newswire (US)	Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	NASDAQ:ALKS	Alkermes PLC
2024/08/22	20:00	PR Newswire (US)	Alkermes Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 2	NASDAQ:ALKS	Alkermes PLC
2024/08/22	20:00	PR Newswire (US)	Alkermes Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 2	NASDAQ:ALKS	Alkermes PLC
2024/08/06	05:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/07/25	05:59	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALKS	Alkermes PLC
2024/07/24	22:23	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALKS	Alkermes PLC
2024/07/24	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALKS	Alkermes PLC
2024/07/24	20:00	PR Newswire (US)	Alkermes plc Reports Second Quarter 2024 Financial Results	NASDAQ:ALKS	Alkermes PLC
2024/07/18	05:00	PR Newswire (US)	Alkermes to Report Second Quarter Financial Results on July 24, 2024	NASDAQ:ALKS	Alkermes PLC
2024/07/18	05:00	PR Newswire (US)	Alkermes to Report Second Quarter Financial Results on July 24, 2024	NASDAQ:ALKS	Alkermes PLC
2024/06/11	09:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/11	09:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/05	05:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALKS	Alkermes PLC
2024/06/03	20:00	PR Newswire (US)	Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024	NASDAQ:ALKS	Alkermes PLC
2024/06/01	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALKS	Alkermes PLC
2024/05/30	05:00	PR Newswire (US)	Alkermes to Participate in Two Upcoming Investor Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/30	05:00	PR Newswire (US)	Alkermes to Participate in Two Upcoming Investor Conferences	NASDAQ:ALKS	Alkermes PLC
2024/05/28	20:00	PR Newswire (US)	Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024	NASDAQ:ALKS	Alkermes PLC
2024/05/28	20:00	PR Newswire (US)	Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024	NASDAQ:ALKS	Alkermes PLC